Need more? Try out  Advanced Search (20+ criteria)»

logo

Last Update

This profile was last updated on 12/5/2016 and contains contributions from the  Zoominfo Community.

is this you? Claim your profile.

Wrong Ciaran Cooper?

Ciaran Cooper

Head of Business Development, Clinical Trials Imaging, North America

MEDIAN Technologies Inc

HQ Phone:  +33 4 93 33 37 77

Direct Phone: (773) ***-****direct phone

GET ZOOMINFO GROW

+ Get 10 Free Contacts a Month

Please agree to the terms and conditions.

I agree to the  Terms of Service and  Privacy Policy. I understand that I will receive a subscription to ZoomInfo Grow at no charge in exchange for downloading and installing the ZoomInfo Contact Contributor utility which, among other features, involves sharing my business contacts as well as headers and signature blocks from emails that I receive.

THANK YOU FOR DOWNLOADING!

computers
  • 1.Download
    ZoomInfo Grow
    v sign
  • 2.Run Installation
    Wizard
  • 3.Check your inbox to
    Sign in to ZoomInfo Grow

I agree to the Terms of Service and Privacy Policy. I understand that I will receive a subscription to ZoomInfo Community Edition at no charge in exchange for downloading and installing the ZoomInfo Contact Contributor utility which, among other features, involves sharing my business contacts as well as headers and signature blocks from emails that I receive.

MEDIAN Technologies Inc

Les Deux Arcs B 1800 route des Cretes

France

Company Description

About MEDIANTechnologies: MEDIAN Technologies develops medical imaging software and services dedicated to oncology clinical trials, cancer screening, and clinical practice. MEDIAN Technologies standardizes and automates the interpretation of medical images in ...more

Background Information

Employment History

Principal

Strategic Business Consultants


Senior Manager In Business Development

several imaging core labs


Web References(18 Total References)


MEDIAN Technologies - News

www.mediantechnologies.com [cached]

MEDIAN Technologies (ALMDT), a leading medical imaging software solutions developer, and a service provider for image interpretation and management in oncology clinical trials, announced today that it has named Ciaran Cooper as Head of Business Development, Clinical Trials Imaging, North America.
Ciaran Cooper will be responsible for developing the company's US market in oncology clinical trials and will assist in managing the strategic relationship between MEDIAN Technologies and Quintiles. Ciaran Cooper, an entrepreneur and early innovator in the clinical trials imaging services industry, brings over 20 years' experience in medical imaging with an emphasis in business development, strategic planning, and team management. Along with colleagues from the University of Chicago, Ciaran Cooper co-founded MIICRO, Inc. in 1995, the first imaging CRO specialized in early phase translational imaging with FDG PET. He was CEO of MIICRO until 2003. Since then, Ciaran Cooper has worked for several imaging services and technology companies as a senior manager in business development and thus brings with him a vast knowledge of various business models, therapeutic areas, and growth strategies. "I'm very excited to join MEDIAN at this time in their development," said Ciaran Cooper. "MEDIAN's LMS solution provides a quantum leap forward in how medical imaging can be applied to oncology clinical trials. I look forward to carrying our message to market." "We're thrilled to welcome Ciaran to our team," said Jerome Windsor, VP Business Development at MEDIAN Technologies. "Ciaran has a unique perspective on the industry and he brings an entrepreneurial spirit and enthusiasm that will fit well with our growing company."


www.investincotedazur.com

MEDIAN Technologies (Sophia Antipolis, France), a leading medical imaging software solutions developer, and a service provider for image interpretation and management in oncology clinical trials, announced today that it has named Ciaran Cooper as Head of Business Development, Clinical Trials Imaging, North America.
Ciaran Cooper will be responsible for developing the company's US market in oncology clinical trials and will assist in managing the strategic relationship between MEDIAN Technologies and Quintiles. Ciaran Cooper, an entrepreneur and early innovator in the clinical trials imaging services industry, brings over 20 years' experience in medical imaging with an emphasis in business development, strategic planning, and team management. Along with colleagues from the University of Chicago, Ciaran Cooper co-founded MIICRO, Inc. in 1995, the first imaging CRO specialized in early phase translational imaging with FDG PET. He was CEO of MIICRO until 2003. Since then, Ciaran Cooper has worked for several imaging services and technology companies as a senior manager in business development and thus brings with him a vast knowledge of various business models, therapeutic areas, and growth strategies. "I'm very excited to join MEDIAN at this time in their development," said Ciaran Cooper."MEDIAN's LMS solution provides a quantum leap forward in how medical imaging can be applied to oncology clinical trials. I look forward to carrying our message to market." "We're thrilled to welcome Ciaran to our team,"said Jerome Windsor, VP Business Development at MEDIAN Technologies. "Ciaran has a unique perspective on the industry and he brings an entrepreneurial spirit and enthusiasm that will fit well with our growing company."


MEDIAN Technologies names Ciaran Cooper as Head of Business Development, Clinical Trials Imaging, North America

www.mediantechnologies.com [cached]

MEDIAN Technologies (ALMDT), a leading medical imaging software solutions developer, and a service provider for image interpretation and management in oncology clinical trials, announced today that it has named Ciaran Cooper as Head of Business Development, Clinical Trials Imaging, North America.
Ciaran Cooper will be responsible for developing the company's US market in oncology clinical trials and will assist in managing the strategic relationship between MEDIAN Technologies and Quintiles. Ciaran Cooper, an entrepreneur and early innovator in the clinical trials imaging services industry, brings over 20 years' experience in medical imaging with an emphasis in business development, strategic planning, and team management. Along with colleagues from the University of Chicago, Ciaran Cooper co-founded MIICRO, Inc. in 1995, the first imaging CRO specialized in early phase translational imaging with FDG PET. He was CEO of MIICRO until 2003. Since then, Ciaran Cooper has worked for several imaging services and technology companies as a senior manager in business development and thus brings with him a vast knowledge of various business models, therapeutic areas, and growth strategies. "I'm very excited to join MEDIAN at this time in their development," said Ciaran Cooper. "MEDIAN's LMS solution provides a quantum leap forward in how medical imaging can be applied to oncology clinical trials. I look forward to carrying our message to market." "We're thrilled to welcome Ciaran to our team," said Jerome Windsor, VP Business Development at MEDIAN Technologies. "Ciaran has a unique perspective on the industry and he brings an entrepreneurial spirit and enthusiasm that will fit well with our growing company."


www.mediantechnologies.com

MEDIAN Technologies (ALMDT), a leading medical imaging software solutions developer, and a service provider for image interpretation and management in oncology clinical trials, announced today that it has named Ciaran Cooper as Head of Business Development, Clinical Trials Imaging, North America.
Ciaran Cooper will be responsible for developing the company's US market in oncology clinical trials and will assist in managing the strategic relationship between MEDIAN Technologies and Quintiles. Ciaran Cooper, an entrepreneur and early innovator in the clinical trials imaging services industry, brings over 20 years' experience in medical imaging with an emphasis in business development, strategic planning, and team management. Along with colleagues from the University of Chicago, Ciaran Cooper co-founded MIICRO, Inc. in 1995, the first imaging CRO specialized in early phase translational imaging with FDG PET. He was CEO of MIICRO until 2003. Since then, Ciaran Cooper has worked for several imaging services and technology companies as a senior manager in business development and thus brings with him a vast knowledge of various business models, therapeutic areas, and growth strategies. "I'm very excited to join MEDIAN at this time in their development," said Ciaran Cooper. "MEDIAN's LMS solution provides a quantum leap forward in how medical imaging can be applied to oncology clinical trials. I look forward to carrying our message to market." "We're thrilled to welcome Ciaran to our team," said Jerome Windsor, VP Business Development at MEDIAN Technologies. "Ciaran has a unique perspective on the industry and he brings an entrepreneurial spirit and enthusiasm that will fit well with our growing company."


Testimonials

markthiel.com [cached]

Ciaran Cooper
Vice President, Clinical Trials Services, M2S Inc.


Similar Profiles

city

Browse ZoomInfo's Business
Contact Directory by City

city

Browse ZoomInfo's
Business People Directory

city

Browse ZoomInfo's
Advanced Company Directory